Stanford scientists have developed innovative methods for safely collecting, preserving, imaging, and molecularly profiling human brain tissue that remains on explanted intracranial electrodes used in neurosurgical procedures.
Stanford researchers have developed a neuromonitoring-guided cognitive intervention that enhances working memory by dynamically identifying and reinforcing engagement of individualized brain networks in real time.
The absence of a remote, reliable measure of rigidity, bradykinesia and tremor is a major limitation for telemedicine and multicenter clinical trials in Parkinson's disease (PD).
Stanford researchers have developed the Large-scale Electrophysiology Amplification Platform (LEAP), a wireless, label-free optical system for monitoring the electrical activity of neurons and heart cells.
Stanford scientists have developed a novel Nerve Decompression Brace capable of decompressing mild nerve compressions, which relieves forearm pain, numbness, and tingling symptoms associated with repetitive strain injuries.
Stanford scientists have developed a wearable neurostimulator device that targets the dorsal genital nerve on the penis to improve and/or expedite male orgasm.
Stanford researchers have developed an innovative brain-machine interface aimed at restoring communication for individuals with paralysis by translating their attempted speech into text.
Stanford researchers have developed a system that addresses a critical challenge in brain-computer interface (BCI) technology: the need for tedious and lengthy recalibration procedures that disrupt daily use.
Researchers in Dr. Michelle Monje-Deisseroth's lab at Stanford have identified therapeutic targets for drug development to limit the spread of high-grade gliomas (HGGs).
Researchers in the Airan Lab have developed a noninvasive method using low intensity transcranial ultrasound to drive cerebrospinal fluid (CSF) glymphatic and lymphatic flow to clear brain injury waste products from CSF and brain interstitium.
Researchers at Stanford University have found that recombinant osteopontin (SPP1) protein reduces foreign body response (FBR) and thereby facilitates successful integration and function of implantable devices.